PL EN


Preferences help
enabled [disable] Abstract
Number of results
2009 | 81 | 8 | 364-371
Article title

Elements of Virchow's Triad in the Prevention and Treatment of Venous Thrombosis

Content
Title variants
Languages of publication
EN
Abstracts
EN
Keywords
Publisher

Year
Volume
81
Issue
8
Pages
364-371
Physical description
Dates
published
1 - 8 - 2009
online
22 - 10 - 2010
Contributors
  • Department of Clinical Biochemistry, Medical Centre of Postgraduate Education in Warsaw
References
  • Virchow R: Phlogose und Thrombose in Gefas-system. W: R. Virchow (red.) Gesammelte Abhandlungen zur Wissenshaftlingen Medizin. Von Meidlingen Sohn, Frankfurt 1856, 458.
  • Wakefield TW, Henke PK: The role of inflammation in early and late venous thrombosis: are there clinical implications? Semin Vasc Surg 2005; 18:118-29.[Crossref][PubMed]
  • Lopez JA, Kearon C, Lee AY: Deep venous thrombosis. Hematology Am Soc Hematol Educ Program 2004; 439-56.[PubMed]
  • Myers DD, Wakefield TW: Inflammation - dependent thrombosis. Front Biosc 2005; 10: 2750-57.[Crossref]
  • Prescott SI, Weyrich AS, Zimmerman GA: Classification of venous thromboembolism (VTE). J Thromb Haemost 2005; 3: 2571-72.[PubMed][Crossref]
  • Day SM, Reeve JL, Pedersen B et al.: Macrovascular thrombosis is driven by tissue factor derived primarily from the vessel wall. Blood 2005; 105: 192-97[Crossref]
  • Van Aken BE, den Heijer M, Bos GMJ et al.: Recurrent Venous Thrombosis and Markers of Inflammation. Thromb Haemost 2000; 83: 536-39.
  • Viles-Gonzales JF, Fuster V, Badimon JJ: Thrombin/inflammation paradigms: a closer look at arterial and venous thrombosis. Am Heart J 2005; 149 (1 Suppl.): S19-S31.
  • Poredos P, Jezovnik MK: The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis. Int Angiol 2007; 26: 306-11.[PubMed]
  • Fox EA, Kahn SR: The relationship between inflammation and venous thrombosis. a systematic review of clinical studies. Thromb Haemost 2005; 94: 362-65.[PubMed]
  • Bucek RA, Reiter M, Quekenberger P et al.: Creactive protein in the diagnosis of deep vein thrombosis. Brit J Haematol 2002; 119: 385-89.[Crossref]
  • Tsai AW, Cushman M, Rosamond WD et al.: Coagulation Factors, Inflammation Markers and Venous Thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Med 2002; 113: 636-42.
  • Reiter M, Bucek RA, Koca N et al.: Deep vein thrombosis and systemic inflammatory response: a pilot trial. Wien Klin Wochensch 2003; 115: 111-14.[Crossref]
  • Hamer JD, Malone PC, Silver A: The PO2 in venous valve pockets: its possible bearing on the thrombogenesis. Brit J Surg 1981; 68: 166-70.[Crossref]
  • Conde J, Lopez JA: Classification of venous thromboembolism (VTE). Role of acute inflammatory stress in venous thromboembolism. J Thromb Haemost 2005; 3: 2571-73.
  • Kearon C: Natural history of venous thromboembolism. Circulation 2003; 107 (suppl. 1): 1-22.
  • Ouriel K, Green RM, Greenberg RK et al.: The anatomy of deep venous thrombosis of the lower extremity. J Vasc Surg 2000; 3: 895-900.[Crossref]
  • Kearon C, Kahn SR, Agnelli G et al.: American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133 (6 Suppl): 454S-545S.
  • Downing LJ, Strieter RM, Kadell AM et al.: Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg 1998; 28: 848-54.[PubMed][Crossref]
  • Wakefield TW, Strieter RM, Prince MR et al.: Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg 1997; 5: 6-15.[PubMed][Crossref]
  • Dawes J: Interaction of heparins in the vascular environment. Haemostasis 1993; 23: 212-19.[PubMed]
  • Tyrrell DJ, Horne AP, Holme KR et al.: Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol 1999; 46: 151-208.[PubMed][Crossref]
  • Eppihimer MJ, Schaub RG: P-selectin-dependent inhibition of thrombosis during venous stasis. Arterioscler Thromb Vasc Biol 2000; 20: 2483-88.[PubMed][Crossref]
  • Myers DD Jr, Wrobleski SK, Longo C et al.: Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation. Thromb Haemost 2007; 97: 400-07.[WoS]
  • Wakefield TW, Strieter RM, Schaub R et al.: Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. J Vasc Surg 2000; 31: 309-24.[Crossref][PubMed]
  • Downing LJ, Wakefield TW, Strieter RM et al.: Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997; 25: 816-28.[Crossref]
  • Myers DDJ, Rectenwald JE, Bedard PW et al.: Decreased venous thrombosis with an oral inhibitor of P-selectin. J Vasc Surg 2005; 42; 329-36.[PubMed][Crossref]
  • Meier TR, Myers DD Jr, Wrobleski SK et al.: Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost 2008; 99: 343-51.[WoS]
  • Downing LJ, Strieter RM, Kadell AM et al.: IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 1998; 161: 1471-76.
  • Grosser T: The pharmacology of selective inhibition of COX-2. Thromb Haemost 2006; 96: 391-400.
  • Szczepański M: Zakrzepica żył głębokich i zakrzepowe zapalenie żył powierzchownych. Wyd.2. PZWL, Warszawa 2007.
  • Doutremepuich C, Lalanne MC, Doutremepuich F et al.: Could non steroidal anti-inflammatory drugs be used to potentiate L. M. W. H. activity in thrombosis? (Part 1). Thromb Res 1991; 63: 13-19.
  • Nielsen HK, Husted SE, Krusell LR et al.: Anticoagulant therapy in deep venous thrombosis. A randomised controlled study. Thromb Res 1994; 73: 215-26.[Crossref]
  • Wang C-J, Wang J-W, Wang L-H et al.: Prevention of Deep-Vein Thrombosis after total knee arthroplasty in Asian Patients. J Bone and Joint Surgery 2004; 86, 1; ProQuest Medical Library, pg. 136.
  • Patrono C, Baigent C, Hirsh J et al.: Antiplatelet Drugs. American College of Chest Physicians, Evidence - Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 199S-233S.
  • Flicoteaux H, Kher A, Jean N et al.: Comparison of low dose heparin and low dose heparin combined with aspirin in prevention of deep vein thrombosis after total hip replacement. Pathologie Biologie (Paris) 1977; 25 (suppl.): 55-58.
  • Vinazzer H, Loew D, Simma W et al.: Prophylaxis of postoperative thromboembolism by low dose heparin and by acetylsalicylic acid given simultaneously. A double blind study. Thromb Res 1980; 17: 177-84.[Crossref]
  • Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308: 235-46.
  • Scottish Intercollegiate Guidelines Network.
  • Geerts WH, Heit JA, Clagett GP et al.: Prevention of venous thromboembolism. Chest 2001; 119 Suppl. 1: 132-75.[WoS]
  • Geerts WH, Bergqvist D, Pineo GF et al.: Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 381S-453S.
  • Łopaciuk S, Zawilska K, Torbicki A i wsp. Wytyczne profilaktyki i leczenia żylnej choroby zakrzepowo-zatorowej. Medycyna Praktyczna 2002; 5 (suppl.).
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_v10035-009-0061-6
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.